Improving treatments for lung cancer with specific MET mutations
Optimizing Treatment Approaches to Lung Cancers Harboring MET Exon 14
['FUNDING_R01'] · FRED HUTCHINSON CANCER CENTER · NIH-11062982
This study is looking at lung cancer patients with changes in the MET gene to find out how these changes affect treatment, so we can discover better therapy options for everyone dealing with this condition.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | FRED HUTCHINSON CANCER CENTER (nih funded) |
| Locations | 1 site (SEATTLE, UNITED STATES) |
| Trial ID | NIH-11062982 on ClinicalTrials.gov |
What this research studies
This research focuses on lung cancer, particularly on patients with mutations in the MET gene, which can affect treatment outcomes. The team aims to optimize targeted therapies by understanding how these mutations influence the effectiveness of existing MET inhibitors. By characterizing the specific changes in the MET gene, the researchers hope to identify better treatment options for a larger group of lung cancer patients. The study will involve laboratory experiments to analyze how these mutations interact with various therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are lung cancer patients who have been diagnosed with MET exon 14 mutations.
Not a fit: Patients without MET mutations or those with other types of lung cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective targeted treatments for lung cancer patients with MET mutations.
How similar studies have performed: Previous research has shown promising results in targeting specific mutations in lung cancer, indicating potential success for this approach.
Where this research is happening
SEATTLE, UNITED STATES
- FRED HUTCHINSON CANCER CENTER — SEATTLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: COLLISSON, ERIC — FRED HUTCHINSON CANCER CENTER
- Study coordinator: COLLISSON, ERIC
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.